Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Zhou, Yang  [Clear All Filters]
Journal Article
Zhou Y, Qian L. Advanced Technologies Lead iNto New Reprogramming Routes. Cell Stem Cell. 2016;19(3):286-288.
Ouyang X, Liu Y, Zhou Y, Guo J, Wei T-T, Liu C, Lee B, Chen B, Zhang A, Casey KM, et al. Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. Stem Cell Reports. 2021.
Zhao M, Zhang E, Wei Y, Zhou Y, Walcott GP, Zhang J. Apical Resection Prolongs the Cell Cycle Activity and Promotes Myocardial Regeneration After Left Ventricular Injury in Neonatal Pig. Circulation. 2020;142(9):913-916.
Zhou Y, Wang L, Vaseghi HRuth, Liu Z, Lu R, Alimohamadi S, Yin C, Fu J-D, Wang GG, Liu J, et al. Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming. Cell Stem Cell. 2016;18(3):382-395.
Zhou Y, Wang Y, Ju X, Lan J, Zou H, Li S, Qi Y, Jia W, Hu J, Liang W, et al. Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis. Biomark Med. 2015:1-14.
Lan J, Huang B, Liu R, Ju X, Zhou Y, Jiang J, Liang W, Shen Y, Li F, Pang L. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors. Int J Clin Exp Pathol. 2015;8(10):12621-33.
Yu Y, Zhang Q, Meng Q, Zong C, Liang L, Yang X, Lin R, Liu Y, Zhou Y, Zhang H, et al. Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages. Oncotarget. 2016.
Liu N, Kan J, Cao W, Cao J, Jiang E, Zhou Y, Zhao M, Feng J. Metagenomic next-generation sequencing diagnosis of peripheral pulmonary infectious lesions through virtual navigation, radial EBUS, ultrathin bronchoscopy, and ROSE. J Int Med Res. 2019:300060519866953.
Zhang T, Zhou Y, Li L, Wang H-H, Ma X-S, Qian W-P, Shen W, Schatten H, Sun Q-Y. SIRT1, 2, 3 protect mouse oocytes from postovulatory aging. Aging (Albany NY). 2016.